Hua Tian, Vemuri Kiran, Nikas Spyros P, Laprairie Robert B, Wu Yiran, Qu Lu, Pu Mengchen, Korde Anisha, Jiang Shan, Ho Jo-Hao, Han Gye Won, Ding Kang, Li Xuanxuan, Liu Haiguang, Hanson Michael A, Zhao Suwen, Bohn Laura M, Makriyannis Alexandros, Stevens Raymond C, Liu Zhi-Jie
iHuman Institute, ShanghaiTech University, Shanghai 201210, China.
National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Nature. 2017 Jul 27;547(7664):468-471. doi: 10.1038/nature23272. Epub 2017 Jul 5.
The cannabinoid receptor 1 (CB) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ-tetrahydrocannabinol (Δ-THC). Here we report two agonist-bound crystal structures of human CB in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841) at 2.80 Å and 2.95 Å resolution, respectively. The two CB-agonist complexes reveal important conformational changes in the overall structure, relative to the antagonist-bound state, including a 53% reduction in the volume of the ligand-binding pocket and an increase in the surface area of the G-protein-binding region. In addition, a 'twin toggle switch' of Phe200 and Trp356 (superscripts denote Ballesteros-Weinstein numbering) is experimentally observed and appears to be essential for receptor activation. The structures reveal important insights into the activation mechanism of CB and provide a molecular basis for predicting the binding modes of Δ-THC, and endogenous and synthetic cannabinoids. The plasticity of the binding pocket of CB seems to be a common feature among certain class A G-protein-coupled receptors. These findings should inspire the design of chemically diverse ligands with distinct pharmacological properties.
大麻素受体1(CB1)是大麻中精神活性成分——部分激动剂Δ-四氢大麻酚(Δ-THC)的主要作用靶点。在此,我们报告了人源CB1与一种四氢大麻酚(AM11542)和一种六氢大麻酚(AM841)分别形成复合物的两种激动剂结合晶体结构,分辨率分别为2.80 Å和2.95 Å。相对于拮抗剂结合状态,这两种CB1-激动剂复合物在整体结构上显示出重要的构象变化,包括配体结合口袋体积减少53%以及G蛋白结合区域表面积增加。此外,通过实验观察到苯丙氨酸(Phe)200和色氨酸(Trp)356(上标表示巴列斯特罗斯-温斯坦编号)的“双切换开关”,这似乎是受体激活所必需的。这些结构揭示了关于CB1激活机制的重要见解,并为预测Δ-THC以及内源性和合成大麻素的结合模式提供了分子基础。CB1结合口袋的可塑性似乎是某些A类G蛋白偶联受体的共同特征。这些发现应能激发具有不同药理特性的化学多样性配体的设计。